Literature DB >> 17854142

Nerve growth factor involvement in liver cirrhosis and hepatocellular carcinoma.

Guido Rasi1, Annalucia Serafino, Lia Bellis, Maria Teresa Lonardo, Federica Andreola, Manuela Zonfrillo, Giovanni Vennarecci, Pasquale Pierimarchi, Paola Sinibaldi Vallebona, Giuseppe Maria Ettorre, Eugenio Santoro, Claudio Puoti.   

Abstract

AIM: To define NGF (nerve growth factor) and its high-affinity receptor trkA(NGF) presence and distribution in fibrotic liver and in HCC, and to verify if NGF might have a role in fibrosis and HCC.
METHODS: Intracellular distribution of NGF and trkA(NGF) were assessed by immunohistochemistry and immuno-electron microscopy in liver specimens from HCC, cirrhosis or both. ELISA was used to measure circulating NGF levels.
RESULTS: NGF and trkA(NGF) were highly expressed in HCC tissue, mainly localized in hepatocytes, endothelial and some Kupffer cells. In the cirrhotic part of the liver they were also markedly expressed in bile ducts epithelial and spindle-shaped cells. Surprisingly, in cirrhotic tissue from patients without HCC, both NGF and trkA(NGF) were negative. NGF serum levels in cirrhotic and/or HCC patient were up to 25-fold higher than in controls.
CONCLUSION: NGF was only detected in liver tissue with HCC present. Intracellular distribution suggests paracrine and autocrine mechanisms of action. Better definition of mechanisms may allow for therapeutic and diagnostic/prognostic use of NGF.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17854142      PMCID: PMC4434623          DOI: 10.3748/wjg.v13.i37.4986

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  33 in total

Review 1.  Nerve growth factor and autoimmune rheumatic diseases.

Authors:  L Aloe; M A Tuveri
Journal:  Clin Exp Rheumatol       Date:  1997 Jul-Aug       Impact factor: 4.473

2.  Immunohistochemical analysis of TrkA neurotrophin receptor expression in human non-neuronal carcinomas.

Authors:  H Koizumi; M Morita; S Mikami; E Shibayama; T Uchikoshi
Journal:  Pathol Int       Date:  1998-02       Impact factor: 2.534

Review 3.  Hepatitis C and hepatocellular carcinoma.

Authors:  A M Di Bisceglie
Journal:  Semin Liver Dis       Date:  1995-02       Impact factor: 6.115

4.  Mitogenic effect of nerve growth factor (NGF) in LNCaP prostate adenocarcinoma cells: role of the high- and low-affinity NGF receptors.

Authors:  M A Sortino; F Condorelli; C Vancheri; A Chiarenza; R Bernardini; U Consoli; P L Canonico
Journal:  Mol Endocrinol       Date:  2000-01

Review 5.  The receptors for nerve growth factor and other neurotrophins.

Authors:  S Raffioni; R A Bradshaw; S E Buxser
Journal:  Annu Rev Biochem       Date:  1993       Impact factor: 23.643

6.  The long-term pathological evolution of chronic hepatitis C.

Authors:  M Yano; H Kumada; M Kage; K Ikeda; K Shimamatsu; O Inoue; E Hashimoto; J H Lefkowitch; J Ludwig; K Okuda
Journal:  Hepatology       Date:  1996-06       Impact factor: 17.425

7.  Expression of NGF in hepatocellular carcinoma cells with its receptors in non-tumor cell components.

Authors:  Yoshihiko Tokusashi; Keiko Asai; Susumu Tamakawa; Masahiro Yamamoto; Masumi Yoshie; Yuji Yaginuma; Naoyuki Miyokawa; Takanori Aoki; Shuichi Kino; Shinichi Kasai; Katsuhiro Ogawa
Journal:  Int J Cancer       Date:  2005-03-10       Impact factor: 7.396

Review 8.  New insights on the involvement of Nerve Growth Factor in allergic inflammation and fibrosis.

Authors:  Alessandra Micera; Ilaria Puxeddu; Luigi Aloe; Francesca Levi-Schaffer
Journal:  Cytokine Growth Factor Rev       Date:  2003-10       Impact factor: 7.638

9.  Production of nerve growth factor by mouse hepatocellular carcinoma cells and expression of TrkA in tumor-associated arteries in mice.

Authors:  Kan Kishibe; Yoshihisa Yamada; Katsuhiro Ogawa
Journal:  Gastroenterology       Date:  2002-06       Impact factor: 22.682

10.  An enzyme-linked immunoassay for nerve growth factor (NGF): a tool for studying regulatory mechanisms involved in NGF production in brain and in peripheral tissues.

Authors:  G Weskamp; U Otten
Journal:  J Neurochem       Date:  1987-06       Impact factor: 5.372

View more
  14 in total

Review 1.  Serum markers of hepatocellular carcinoma.

Authors:  Giulia Malaguarnera; Maria Giordano; Isabella Paladina; Massimiliano Berretta; Alessandro Cappellani; Mariano Malaguarnera
Journal:  Dig Dis Sci       Date:  2010-03-26       Impact factor: 3.199

2.  Use of protein array technology to investigate receptor tyrosine kinases activated in hepatocellular carcinoma.

Authors:  Shi Liu; Jian Gong; Asahiro Morishita; Takako Nomura; Hisaaki Miyoshi; Joji Tani; Kiyohito Kato; Hirohito Yoneyama; Akihiro Deguchi; Hirohito Mori; Shima Mimura; Kei Nomura; Takashi Himoto; Kazushi Deguchi; Keiichi Okano; Kunihiko Izuishi; Yasuyuki Suzuki; Yoshio Kushida; Reiji Haba; Hisakazu Iwama; Tsutomu Masaki
Journal:  Exp Ther Med       Date:  2011-02-08       Impact factor: 2.447

Review 3.  Autocrine regulation of biliary pathology by activated cholangiocytes.

Authors:  Kendal Jensen; Marco Marzioni; Kamruzzaman Munshi; Syeda Afroze; Gianfranco Alpini; Shannon Glaser
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-12-22       Impact factor: 4.052

Review 4.  Cholangiocyte proliferation and liver fibrosis.

Authors:  Shannon S Glaser; Eugenio Gaudio; Tim Miller; Domenico Alvaro; Gianfranco Alpini
Journal:  Expert Rev Mol Med       Date:  2009-02-25       Impact factor: 5.600

5.  Human gallbladder carcinoma: Role of neurotrophins, MIB-1, CD34 and CA15-3.

Authors:  M Artico; E Bronzetti; V Alicino; B Ionta; S Bosco; C Grande; M Bruno; F M Tranquilli Leali; G Ionta; L Fumagalli
Journal:  Eur J Histochem       Date:  2010-03-11       Impact factor: 3.188

6.  Serum Cytokine of IL-10 and IL-12 in Chronic Liver Disease: The Immune and Inflammatory Response.

Authors:  Hoda Mohamed El-Emshaty; Wesam Ahmad Nasif; Ibrahim Eldsoky Mohamed
Journal:  Dis Markers       Date:  2015-12-10       Impact factor: 3.434

Review 7.  Tissue- and Serum-Associated Biomarkers of Hepatocellular Carcinoma.

Authors:  Ranjit Chauhan; Nivedita Lahiri
Journal:  Biomark Cancer       Date:  2016-07-04

8.  TrkA is a binding partner of NPM-ALK that promotes the survival of ALK+ T-cell lymphoma.

Authors:  Wenyu Shi; Suraj Konnath George; Bhawana George; Choladda V Curry; Albina Murzabdillaeva; Serhan Alkan; Hesham M Amin
Journal:  Mol Oncol       Date:  2017-06-18       Impact factor: 6.603

9.  Nerve growth factor upregulates sirtuin 1 expression in cholestasis: a potential therapeutic target.

Authors:  Ming-Shian Tsai; Po-Huang Lee; Cheuk-Kwan Sun; Ting-Chia Chiu; Yu-Chun Lin; I-Wei Chang; Po-Han Chen; Ying-Hsien Kao
Journal:  Exp Mol Med       Date:  2018-01-12       Impact factor: 8.718

Review 10.  Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications.

Authors:  Massimiliano Berretta; Carla Cavaliere; Lara Alessandrini; Brigida Stanzione; Gaetano Facchini; Luca Balestreri; Tiziana Perin; Vincenzo Canzonieri
Journal:  Oncotarget       Date:  2017-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.